This week’s guest on the Cannabis Conversation is Ken Clement, Executive Chairman of PRM Inc. – a vertically integrated Canadian phytopharmaceutical company.
In this show, we explore how manipulating environmental conditions can help to produce standardised plant compounds for medical use, and how this complex process differs from GMO.
→ View full show notes, summary, and access resources from this episode here:
Ken has been a successful serial entrepreneur building on 35 years of experience in multiple sectors. His experience in high level team sports along with numerous successful projects has influenced him to build strong teams reliant on passion, integrity and work ethic. His vision is unique in the medical cannabis sector with the concept of standardized production and dosage. Ken enjoys a strong rapport with regulatory organizations, scientists, thought leaders and numerous strategic partnerships worldwide. Ken has a proven track record, having built ABcann Global from an idea to a company valued in excess of $400 million.
‘The future of medicine… is to get it as clean and as pure as possible’ 27:45